Wabnitz Ashley, Chimowitz Marc
Department of Neurology, Medical University of South Carolina, Charleston, SC, USA.
J Stroke. 2017 Sep;19(3):271-276. doi: 10.5853/jos.2017.01837. Epub 2017 Sep 29.
Although there is an intuitive appeal to treat symptomatic stenotic intracranial arteries with endovascular therapies such as angioplasty and stenting, current data from randomized trials show intensive medical therapy is far superior for preventing stroke. This is in large part due to the high risk of peri-procedural stroke from angioplasty and stenting. If angioplasty and stenting is to emerge as a proven treatment for intracranial stenosis, endovascular techniques will need to become much safer, identification of patients with intracranial stenosis who are at particularly high risk of stroke despite intensive medical therapy will need to be targeted, and well-designed randomized trials will be necessary to show endovascular therapy is superior to medical therapy in these high-risk patients.
尽管采用血管成形术和支架置入术等血管内治疗方法来治疗有症状的颅内动脉狭窄在直观上具有吸引力,但随机试验的当前数据表明,强化药物治疗在预防中风方面要优越得多。这在很大程度上是由于血管成形术和支架置入术存在围手术期中风的高风险。如果血管成形术和支架置入术要成为颅内狭窄的一种经证实的治疗方法,血管内技术将需要变得更加安全,需要针对那些尽管接受了强化药物治疗但仍有特别高的中风风险的颅内狭窄患者进行识别,并且需要精心设计的随机试验来证明血管内治疗在这些高风险患者中优于药物治疗。